Skip to main
PSTI
PSTI logo

Pluristem Therapeutics (PSTI) Market Capitalization Overview

Market Cap: $40.30M as of Jul 16, 2025

$40.30M
Past Month+$5.84M (16.93%)
As of Jul 16, 2025, Pluristem Therapeutics (PSTI) has a market capitalization of $40.30M. Over the past 30 days, its market cap has increased by 8.05%, while in the last 12 months, it has increased by 69.58%.

Market capitalization represents the total value of Pluristem Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Pluristem Therapeutics (PSTI) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Pluristem Therapeutics (PSTI) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Pluristem Therapeutics (PSTI) Market Cap History

DateMarket CapChange
Jul 1, 2025$37.84M+8.05%
Jun 2, 2025$35.02M+4.70%
May 1, 2025$33.44M+10.93%
Apr 1, 2025$30.15M-7.21%
Mar 3, 2025$32.49M+29.87%
Feb 3, 2025$25.02M+3.93%
Jan 2, 2025$24.07M-18.76%

Pluristem Therapeutics (PSTI) End of Year Market Cap History

DateMarket CapChange
2025$40.30M+69.58%
2024$23.77M-87.64%
2023$192.31M-21.70%
2022$245.61M-34.49%
2021$374.93M-74.14%
2020$1.45B

FAQs About Pluristem Therapeutics (PSTI) Market Cap

As of Jul 16, 2025, the market capitalization of Pluristem Therapeutics (PSTI) is $40.30M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Pluristem Therapeutics’s market capitalization has increased by 16.93%, changing from $34.47M to $40.30M as of Jul 16, 2025.

In the last 3 months, Pluristem Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Pluristem Therapeutics’s market capitalization decreased from $192.31M in January to $23.77M in December, reflecting a -87.64% change.

In the past five years, Pluristem Therapeutics (PSTI) has had a compound annual growth rate (CAGR) of -56.05% in market capitalization. This means its market cap has shrunk at an average rate of -56.05% per year.

Pluristem Therapeutics (PSTI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.